Skip to main content

Abstract

γ-Aminobutyric acid (GABA) and GABA-rich foods have shown anti-hypertensive and anti-depressant activities as the major functions in humans and animals. Hence, high GABA-producing lactic acid bacteria (LAB) could be used as functional starters for manufacturing novel fermented dairy foods. Glutamic acid decarboxylases (GADs) from LAB are highly conserved at the species level based on the phylogenetic tree of GADs from LAB. Moreover, two functionally distinct GADs and one intact gad operon were observed in all the completely sequenced Lactobacillus brevis strains suggesting its common capability to synthesize GABA. Difficulties and strategies for the manufacture of GABA-rich fermented dairy foods have been discussed and proposed, respectively. In addition, a genetic survey on the sequenced LAB strains demonstrated the absence of cell envelope proteinases in the majority of LAB including Lb. brevis, which diminishes their cell viabilities in milk environments due to their non-proteolytic nature. Thus, several strategies have been proposed to overcome the non-proteolytic nature of Lb. brevis in order to produce GABA-rich dairy foods.

Keywords: Lactobacillus brevis; cell envelope proteinase; dairy fermentation; dairy starter culture; glutamic acid decarboxylase; γ-aminobutyric acid.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevisReduced Depression SymptomsBeneficial
Moderate
Lactobacillus brevisReduced HypertensionBeneficial
Large
Lactobacillus brevis HA-112Reduced Blood PressureBeneficial
Moderate
Lactobacillus brevis HA-112Reduced Depression SymptomsBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.